Upfront transplantation for poor-risk aggressive non-Hodgkin lymphoma and Hodgkin's disease: who benefits?

Current oncology reports

Volumn 3, Issue 3, 2001, Pages 271-278

  Kewalramani, T ^a   Moskowitz, C H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AUTOTRANSPLANTATION; DISEASE COURSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; NONHODGKIN LYMPHOMA; PROGNOSIS; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035350842     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-001-0061-0     Document Type: Review

References (50)